Study Stopped
No participants met all the inclusion criteria required within the recruitment time period
Urinary Catheter 'Fill and Flush' Valve: Safety, Effectiveness, Acceptability and Feasibility Trial
2 other identifiers
interventional
N/A
1 country
1
Brief Summary
The fill and flush valve (valve) is an automated valve which is designed to open in response to rising bladder pressure which occurs as the bladder becomes full. The valve is situated between the IDC and the drainage bag as a manual valve would be.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Feb 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 21, 2019
CompletedFirst Posted
Study publicly available on registry
January 28, 2020
CompletedStudy Start
First participant enrolled
February 13, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 18, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 18, 2023
CompletedOctober 6, 2023
October 1, 2023
1.4 years
August 21, 2019
October 3, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Safety: Reliability
Valve opening - Proportion of observations of automatic valve opening before bladder capacity (500ml or less) is reached - as measured by bladder scanner
An average of 16 hours in total
Safety: Effectiveness
Bladder emptying - proportion of valve voids with residual urine \<100ml - as measured by bladder scanner.
An average of 16 hours in total
Safety: Effectiveness
Bladder emptying - Participant report (Valve self-report questionnaire)
An average of 16 hours in total
Comfort
Participant report (Valve self-report questionnaire)
An average of 16 hours in total
Secondary Outcomes (3)
User acceptability
An average of 16 hours in total
User acceptability
An average of 16 hours in total
User acceptability
An average of 16 hours in total
Study Arms (2)
1 - standard manual valve (without leg-bag)
EXPERIMENTALThe valve will initially be tested in 8 participants who currently use a standard manual valve (without leg-bag). This first group will include a safety cohort of participants (n=4). All safety data will be reviewed from the initial 4 participants before further participants can undergo the study investigation.
2 - drainage bag with free drainage
EXPERIMENTALThe valve will then be tested with participants (n=8) who currently use a drainage bag with free drainage.
Interventions
The fill and flush valve (Figure 1) is an automated valve which is designed to open in response to rising bladder pressure which occurs as the bladder becomes full. The valve is situated between the IDC and the drainage bag as a manual valve would be. There are three variants of the valve which respond to different degrees of bladder pressure. People's bladders function at different pressure levels. One of the aims of this study is to gain preliminary data on which valve variant works and under which circumstances. Pressure ranges are as follows: Low: 22 - 49cm H2O Medium: 35 - 61cm H2O High: 53 - 79cm H2O
Eligibility Criteria
You may qualify if:
- IDC-users (urethral or suprapubic), over 18, who have had a catheter in situ for at least one month and use a manual valve or drainage bag to collect urine
- Independent with catheter care needs (e.g. bag emptying or valve opening)
- Able to transfer from bed to chair, stand and walk short distances unaided
- Able to drink moderate levels of fluid (500mls in the first 2 hours and 150mls per hour thereafter)
- Able to provide informed consent (self-report and research nurse assessment)
- Usual medical provider provides confirmation of suitability
You may not qualify if:
- End stages of a terminal illness
- Current treatment of urinary tract infection
- Has been advised by a urologist against using a valve on clinical grounds
- Lack of bladder sensation (e.g. unable to sense when bladder needs emptying)
- Previous bladder surgery that could affect the integrity of the bladder
- At known risk of autonomic dysreflexia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Southamptonlead
- National Institute for Health Research, United Kingdomcollaborator
- BlueWind Medicalcollaborator
- University Hospital Southampton NHS Foundation Trustcollaborator
Study Sites (1)
University Hospital Southampton
Southampton, Hampshire, SO16 6RL, United Kingdom
Study Officials
- PRINCIPAL INVESTIGATOR
Cathy Murphy
University of Southampton
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DEVICE FEASIBILITY
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 21, 2019
First Posted
January 28, 2020
Study Start
February 13, 2022
Primary Completion
July 18, 2023
Study Completion
July 18, 2023
Last Updated
October 6, 2023
Record last verified: 2023-10
Data Sharing
- IPD Sharing
- Will not share